跳至主要内容
临床试验/NCT04759495
NCT04759495Unknown不适用

Comparison of CGM in Non-randomised Real Life Study of Real-time and Intermittently Scanned Systems in Patients With Type 1 Diabetes

Charles University, Czech Republic1 个研究点 分布在 1 个国家目标入组 187 人开始时间: 2019年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
187
试验地点
1
主要终点
Changes in glycated haemoglobin (HbA1c)

研究概览

简要总结

The aim of the investigator's study is to compare real-time continuous glucose monitoring (rt-CGM) and flash glucose monitoring (FGM) in adult patients with Type 1 Diabetes (T1D) in real life practice during 24 weeks of follow-up.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with T1D naive to rt-CGM and FGM
  • Type 1 diabetes for > 1 year
  • ≥ 18 years old
  • CSII without automatic functions or MDI

排除标准

  • previous rtCGM or FGM use
  • treatment with insulin pump with automatic functions
  • severe noncompliance
  • known severe diabetic retinopathy and/or macular edema
  • lactation, pregnancy, or intending to become pregnant during the study
  • a condition likely to require MRI
  • use of acetaminophen-containing medication
  • unwillingness to use the study device for >70% of time

结局指标

主要结局

Changes in glycated haemoglobin (HbA1c)

时间窗: Up to 13 months

Differences between HbA1c values in the Run in period and after 12 month of follow-up and differences of HbA1c between groups.

次要结局

  • Percentage of time in hyperglycemic ranges(Up to 13 months)
  • Percentage of time in hypoglycemic ranges(Up to 13 months)
  • Changes in glycemic variability(Up to 13 months)
  • Incidence of severe ketoacidosis(Up to 13 months)
  • Incidence of skin reaction, infection or hematoma at the site of insertion of the sensor(Up to 13 months)
  • Mean sensor glucose concentration(Up to 13 months)
  • Incidence of severe hypoglycaemia(Up to 13 months)
  • Percentage of time in target ranges(Up to 13 months)

研究者

发起方
Charles University, Czech Republic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jan Soupal, MD

Principal Investigator

Charles University, Czech Republic

研究点 (1)

Loading locations...

相似试验